Jan Loeffen

3.3k total citations
57 papers, 1.9k citations indexed

About

Jan Loeffen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jan Loeffen has authored 57 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Pathology and Forensic Medicine and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jan Loeffen's work include Mitochondrial Function and Pathology (12 papers), Metabolism and Genetic Disorders (10 papers) and Genetic factors in colorectal cancer (9 papers). Jan Loeffen is often cited by papers focused on Mitochondrial Function and Pathology (12 papers), Metabolism and Genetic Disorders (10 papers) and Genetic factors in colorectal cancer (9 papers). Jan Loeffen collaborates with scholars based in Netherlands, Germany and Austria. Jan Loeffen's co-authors include Roel Smeets, Jan Smeıtınk, Lambert van den Heuvel, Frans J.M. Trijbels, Ralf Triepels, R. C. A. Sengers, Orly Elpeleg, Edwin C.M. Mariman, Markus Schuelke and Carin A. F. Buskens and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer.

In The Last Decade

Jan Loeffen

56 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Loeffen Netherlands 21 1.1k 576 254 200 189 57 1.9k
G. Del Toro United States 13 481 0.4× 847 1.5× 118 0.5× 136 0.7× 163 0.9× 25 1.6k
Martina Weise Germany 22 845 0.8× 121 0.2× 63 0.2× 170 0.8× 297 1.6× 39 2.4k
Catherine Rehder United States 24 572 0.5× 83 0.1× 209 0.8× 65 0.3× 216 1.1× 75 1.9k
Pamela Arn United States 20 361 0.3× 294 0.5× 103 0.4× 197 1.0× 32 0.2× 36 1.8k
Indraneel Banerjee United Kingdom 23 454 0.4× 75 0.1× 74 0.3× 493 2.5× 201 1.1× 110 1.9k
Xin Sheng China 20 956 0.9× 102 0.2× 76 0.3× 110 0.6× 93 0.5× 49 1.7k
Emma L. Williams United Kingdom 24 855 0.8× 96 0.2× 451 1.8× 72 0.4× 69 0.4× 56 1.6k
Kyriakie Sarafoglou United States 23 880 0.8× 384 0.7× 32 0.1× 133 0.7× 80 0.4× 89 1.6k
Ishwar C. Verma India 20 625 0.6× 246 0.4× 40 0.2× 220 1.1× 30 0.2× 139 1.7k
Carlos Alberto Longui Brazil 21 595 0.5× 59 0.1× 69 0.3× 180 0.9× 109 0.6× 109 1.5k

Countries citing papers authored by Jan Loeffen

Since Specialization
Citations

This map shows the geographic impact of Jan Loeffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Loeffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Loeffen more than expected).

Fields of papers citing papers by Jan Loeffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Loeffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Loeffen. The network helps show where Jan Loeffen may publish in the future.

Co-authorship network of co-authors of Jan Loeffen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Loeffen. A scholar is included among the top collaborators of Jan Loeffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Loeffen. Jan Loeffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gorris, Mark A.J., Gerty Schreibelt, Sjors Middelkamp, et al.. (2025). Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiency. Nature Communications. 16(1). 4459–4459. 2 indexed citations
2.
Dijk, Freerk van, Lars T. van der Veken, Manon M. H. Huibers, et al.. (2025). Exploring germline variants in genes associated with inborn errors of immunity and inherited bone marrow failure syndromes in pediatric hematological malignancies. European Journal of Cancer. 226. 115598–115598. 1 indexed citations
3.
Hirsch, Steffen, Lennart Kester, Mariëtte E.G. Kranendonk, et al.. (2024). Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations. International Journal of Cancer. 154(8). 1455–1463. 4 indexed citations
4.
Bladergroen, Reno S., Lennart Kester, Marijn A. Vermeulen, et al.. (2024). T-cell lymphoblastic lymphoma compared with T-cell acute lymphoblastic leukemia: similar subtypes and different fusions. PubMed. 1(3). 100029–100029. 2 indexed citations
5.
Guerrini‐Rousseau, Léa, Richard Gallon, Marta Pineda, et al.. (2024). Report of the sixth meeting of the European Consortium ‘Care for CMMRD’ (C4CMMRD), Paris, France, November 16th 2022. Familial Cancer. 23(4). 447–457. 3 indexed citations
6.
Dijk, Freerk van, Marco J. Koudijs, Reno S. Bladergroen, et al.. (2024). Comparison of clinical selection-based genetic testing with phenotype-agnostic extensive germline sequencing to diagnose genetic predisposition in children with cancer: a prospective diagnostic study. The Lancet Child & Adolescent Health. 8(10). 751–761. 2 indexed citations
7.
Hopman, Saskia, Machteld I. Bosscha, Charlotte J. Dommering, et al.. (2023). Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm. JAMA Network Open. 6(2). e2254157–e2254157. 19 indexed citations
8.
Padilla, Laura, Birgit Burkhardt, Andishe Attarbaschi, et al.. (2023). 18F‐FDG‐PET/CT imaging in diagnostic workup of pediatric precursor B‐cell lymphoblastic lymphoma. Pediatric Blood & Cancer. 70(11). e30642–e30642. 2 indexed citations
9.
Beishuizen, Auke, Melanie M. Hagleitner, Jan Loeffen, et al.. (2023). Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma. Frontiers in Immunology. 14. 1229558–1229558. 4 indexed citations
10.
Padilla, Laura, Judith M. Boer, Melanie M. Hagleitner, et al.. (2022). Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement. Cancers. 14(16). 3895–3895. 6 indexed citations
11.
Pastorczak, Agata, Andishe Attarbaschi, Simon Bomken, et al.. (2022). Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders. Cancers. 14(8). 2000–2000. 11 indexed citations
12.
Loeffen, Jan, et al.. (2020). T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?. Blood Advances. 4(14). 3466–3473. 34 indexed citations
13.
Draaisma, Jos, et al.. (2019). Measuring situation awareness and team effectiveness in pediatric acute care by using the situation global assessment technique. European Journal of Pediatrics. 178(6). 837–850. 29 indexed citations
14.
Bomken, Simon, Jutte van der Werff ten Bosch, Andishe Attarbaschi, et al.. (2018). Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group. Frontiers in Immunology. 9. 2912–2912. 40 indexed citations
15.
Kerkhofs, Thomas, Rob H.A. Verhoeven, Gertjan J.L. Kaspers, et al.. (2014). Adrenocortical carcinoma in children: First population-based clinicopathological study with long-term follow-up. Oncology Reports. 32(6). 2836–2844. 34 indexed citations
16.
Elstak, Edo, D. Maroeska W. M. te Loo, Kiki Tesselaar, et al.. (2011). A novel Dutch mutation in UNC13D reveals an essential role of the C2B domain in munc13‐4 function. Pediatric Blood & Cancer. 58(4). 598–605. 8 indexed citations
17.
Triepels, Ralf, Lambertus P. van den Heuvel, Jan Loeffen, et al.. (1999). Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Annals of Neurology. 45(6). 787–790. 164 indexed citations
18.
Loeffen, Jan, Ralf Triepels, Lambertus P. van den Heuvel, et al.. (1998). cDNA of Eight Nuclear Encoded Subunits of NADH:Ubiquinone Oxidoreductase: Human Complex I cDNA Characterization Completed. Biochemical and Biophysical Research Communications. 253(2). 415–422. 61 indexed citations
19.
Heuvel, Lambert van den, W. Ruitenbeek, Roel Smeets, et al.. (1998). Demonstration of a New Pathogenic Mutation in Human Complex I Deficiency: A 5-bp Duplication in the Nuclear Gene Encoding the 18-kD (AQDQ) Subunit. The American Journal of Human Genetics. 62(2). 262–268. 224 indexed citations
20.
Loeffen, Jan, Roel Smeets, Jan Smeıtınk, et al.. (1998). The X‐chromosomal NDUFA1 gene of complex I in mitochondrial encephalomyopathies: Tissue expression and mutation detection. Journal of Inherited Metabolic Disease. 21(3). 210–215. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026